Back

RESEARCH PLATFORM 1

R.P 1.3 Advanced Technologies for Prediction of Myopia Progression

Principle Investigators

PolyU

Prof. Ho-lung Henry CHAN

Prof. Chea-su KEE

UWaterloo

Prof. Daphne MCCULLOCH

Prof. Benjamin THOMPSON

Co-I

Dr. Kai-yip CHOI

Prof. Mingguang HE

Dr. Byung-soo Jeremy KANG

Prof. Tsz-wing Jeffrey LEUNG

Dr. Ellen TAN

Dr. Vivian CHOH

Dr. Natalie NUTCHINGS

Prof. Elizabeth IRVING

Dr. Vivek MAHESHWARI

Prof. Stanley WOO

Overview

This project targets comprehensive myopia management through two complementary technology areas. The first focuses on developing, clinically validating, and commercializing a Digital Myopia Control (d.MC™) platform that uses patented AI-based predictive algorithms and ocular biometric data to monitor eye growth and deliver personalized myopia control plans. In parallel, the project advances structured light technology to detect and monitor myopia progression by analysing subtle perceptual differences arising from changes in retinal structure and optics. Research activities focus on refining predictive models, modifying structured-light stimuli, and validating these tools for early detection and long-term monitoring of myopia.

Learn more about R.P 1.2 Learn more about R.P 1.4

R.P 1.1 Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

Development and Clinical Validation of AI-Based Software as a Medical Device for Non-Invasive Ophthalmic Imaging and Automated Reporting

R.P 1.2 Anti-Myopia Electronic Displays: Making Screens Eye-Safe for Children

R.P 1.4 Targeting Higher-Level Brain Functions for Amblyopia Rehabilitation

R.P 1.5 Novel Neuromodulation Approaches for Vision Enhancement in Adults

R.P 2.1 Clinical Translation of a Novel Anti-Microbial Therapy for Eye Infections

R.P 2.2 An Organoid Platform and Cell-Based Platform for Ocular Therapeutic Development

R.P 2.3 Developing Next-Generation Therapeutic Agents for Glaucoma

R.P 2.4 Novel Gene Delivery Platforms for the Treatment of Ocular Disease

R.P 2.5 Integrated Dry Eye Diagnosis and Precision Therapies

R.P 2.6 Development of Ocular Inserts and Aptamer-Based Delivery Vehicles for Sustained Release of Ocular Therapeutics and TCM Products

R.P 3.1 Eye Disease Diagnosis and Treatment Enabled by Novel Retinal Instrumentation

R.P 3.2 Non-Invasive Tear-Based Diagnostic System

R.P 3.3 Development of New-Generation Contact Lenses Using Novel Materials and Additive Manufacturing

R.P 3.4 Detection of Macular Degeneration and Myopia-Induced Retinal Damage Using Structured Light Technology

R.P 3.5 Extended Reality Visual Intelligence System (XRVIS) for Tele-Visual Assessment and Safety Enhancement for People with Visual Impairment

ENQUIRY